Malignant neoplasm of retina
This is a study to compare two chemotherapy regimens (Standard dose CEV vs High dose CEV) in retinoblastoma to find out, if higher dose regimen saves vision and eyeball better as compared to the standard dose regimen.
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical SciencesNew Delhi, DelhiDirections ↗
Registry summary (technical)
StandArd VEC vs high dose VEC with local THErapy for VIsion and globe Salvage in advanced IntraOcular retiNoblastoma (group D): A comparative RCT (SAVE-THE-VISION) study
Sponsor: All India Institute of Medical Sciences New Delhi
CTRI/2024/03/064078 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 12 Jan 2026 · read by us 5 Nov 2026